Sciwind Biosciences

http://www.sciwind.com.cn/

Weekly News Amount
Total
${lastRankDetail.pages.length}
Financing ${lastRankDetail.financing_pages.length}
Product ${lastRankDetail.product_pages.length}
Negative ${lastRankDetail.sentiment_pages.length}
Sciwind Biosciences is a drug developer for metabolic diseases. The company is mainly engaged in the research of drugs for fatty hepatitis, liver fibrosis, liver cirrhosis and other related metabolic diseases, and involves the research and development of new biological drugs with independent intellectual property rights

Transactions

Funding 2 Fundings

Signals

Events ${currentEventsPage.count} Events
Events (${currentEventsPage.count}) Date
Nothing Happens :-(
${e.desp} ${e.date}
News ${ rankDetail.pages.length } News Articles ${currentTimeRange.start} ~ ${currentTimeRange.end}
Article (${rankDetail.pages.length}) Tag
${article.en_title} ${article.tag}
Industry Financing Info

Research

Intelligence 0 Research Briefs

Competition

Competitors 5 Competitors
Company Industry Series Amount Announced Date

LanssonPharm

LanssonPharm is a new drug research and development service provider, specializing in drug design, drug target identification, new drug structure design, pharmaceutical research, drug screening and evaluation and other fields, focusing on drug research and development of major diseases of the central nervous system, and carrying out drug informatics, new drug declaration, new drug policy consultation and other services

Healthcare

series A

Tens of millions CNY

28/1/2019

BociMed

BociMed is an enterprise engaged in drug research and development and clinical research. It provides high-quality research and development and outsourcing services including drug discovery, preclinical pharmaceutical research and development, clinical phase I-IV trials and registration declaration for enterprises through the establishment of a standardized service system

Healthcare

series B

Undisclosed

3/10/2020

MabPlex

MabPlex is a one-stop outsourcing service provider for biopharmaceutical research and development and GMP production. The company mainly provides users with a series of biopharmaceutical research and development and production outsourcing services such as monoclonal antibody, recombinant protein, antibody drug coupling, etc. It can also provide the whole process solution of cytotoxin synthesis, linker production and coupling during antibody drug coupling ( ADC ) drug research and development

Healthcare

series B

500 million CNY

8/6/2020

ZhiShanWeiXin

ZhiShanWeiXin is a biotechnology enterprise focusing on gene therapy and integrating gene drug research and development, technical service, technology transformation, large-scale production and sales. The future development of gene therapy drugs in ZhiShanWeiXin will focus on genetic diseases and neurodegenerative diseases

Healthcare

series A

Hundreds of millions CNY

9/2/2021

DingKeYiLiao

DingKeYiLiao is a high-tech company specializing in the research and development and production of vascular interventional medical treatment products, and has completed several registration tests and animal experiments of three types of products, among which DingKeYiLiao has the pre-market clinical trial of coronary drug balloon DCB ( Drug Coated Balloon ) Dissove TM with independent PCT intellectual property rights

Healthcare

series B

Nearly 100 million CNY

18/8/2020